Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome

Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome

Efficacy, tolerability and cardioprotective properties of rilmenidine were examined in patients with mild to moderate arterial hypertension (AH). The trial involved 51 hypertensive subjects, mean age 57,7+2,5 years. After wash-out period, rilmenidine was administered in the daily dose of 1-2 mg. At...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy: S. S. Yakushin, N. I. Ivankova, N. S. Sazonova, N. V. Vilesova, G. O. Ivanova
Format: Artykuł
Język:Russian
Wydane: «FIRMA «SILICEA» LLC 2004-12-01
Seria:Российский кардиологический журнал
Hasła przedmiotowe:
arterial hypertension
metabolic syndrome
cardioprotective effects
rilmenidine
Dostęp online:https://russjcardiol.elpub.ru/jour/article/view/2326

Internet

https://russjcardiol.elpub.ru/jour/article/view/2326

Podobne zapisy